Perniok A - Search Results

1

Involvement of soluble CD95 in Churg-Strauss syndrome.

Müschen M, Warskulat U, Perniok A, Even J, Moers C, Kismet B, Temizkan N, Simon D, Schneider M, Häussinger D. Müschen M, et al. Among authors: perniok a. Am J Pathol. 1999 Sep;155(3):915-25. doi: 10.1016/S0002-9440(10)65191-7. Am J Pathol. 1999. PMID: 10487849 Free PMC article.

2

High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.

Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. Perniok A, et al. Lupus. 1998;7(2):113-8. doi: 10.1191/096120398678919804. Lupus. 1998. PMID: 9541096

3

Detection of cerebral microemboli in APS--introducing a novel investigation method and implications of analogies with carotid artery disease.

Specker C, Perniok A, Brauckmann U, Siebler M, Schneider M. Specker C, et al. Among authors: perniok a. Lupus. 1998;7 Suppl 2:S75-80. doi: 10.1177/096120339800700217. Lupus. 1998. PMID: 9814678 Review.

4

Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells.

Plum J, Razeghi P, Lordnejad RM, Perniok A, Fleisch M, Fusshöller A, Schneider M, Grabensee B. Plum J, et al. Among authors: perniok a. Am J Kidney Dis. 2001 Oct;38(4):867-75. doi: 10.1053/ajkd.2001.27709. Am J Kidney Dis. 2001. PMID: 11576893

5

Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.

Gaubitz M, Seidel M, Kummer S, Schotte H, Perniok A, Domschke W, Schneider M. Gaubitz M, et al. Among authors: perniok a. J Autoimmun. 1998 Oct;11(5):495-501. doi: 10.1006/jaut.1998.0229. J Autoimmun. 1998. PMID: 9802935 Clinical Trial.

6

Immunoadsorption in systemic connective tissue diseases and primary vasculitis.

Schneider M, Gaubitz M, Perniok A. Schneider M, et al. Among authors: perniok a. Ther Apher. 1997 May;1(2):117-20. doi: 10.1111/j.1744-9987.1997.tb00024.x. Ther Apher. 1997. PMID: 10225754 Review.

7

Fas-Mediated apoptosis is inhibited by TSH and iodine in moderate concentrations in primary human thyrocytes in vitro.

Feldkamp J, Pascher E, Perniok A, Scherbaum WA. Feldkamp J, et al. Among authors: perniok a. Horm Metab Res. 1999 Jun;31(6):355-8. doi: 10.1055/s-2007-978753. Horm Metab Res. 1999. PMID: 10437622

8

First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104.

Iking-Konert C, Stocks S, Weinsberg F, Engelbrecht R, Bleck E, Perniok A, Fischer-Betz R, Pincus S, Nardone L, Schneider M. Iking-Konert C, et al. Among authors: perniok a. Ann Rheum Dis. 2004 Sep;63(9):1104-12. doi: 10.1136/ard.2003.016691. Ann Rheum Dis. 2004. PMID: 15308520 Free PMC article. Clinical Trial.

9

Effect of 1alpha,25(OH)2-vitamin D3 on TNF alpha-mediated apoptosis of human primary osteoblast-like cells in vitro.

Pascher E, Perniok A, Becker A, Feldkamp J. Pascher E, et al. Among authors: perniok a. Horm Metab Res. 1999 Dec;31(12):653-6. doi: 10.1055/s-2007-978815. Horm Metab Res. 1999. PMID: 10668917

10

Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systemic lupus erythematosus patients and autoantibody-producing cell lines.

Kurth J, Perniok A, Schmitz R, Iking-Konert C, Chiorazzi N, Thompson KM, Winkler T, Rajewsky K, Küppers R. Kurth J, et al. Among authors: perniok a. Eur J Immunol. 2002 Dec;32(12):3785-92. doi: 10.1002/1521-4141(200212)32:12<3785::AID-IMMU3785>3.0.CO;2-E. Eur J Immunol. 2002. PMID: 12516573 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page